Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in number of shares and votes in Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B) has performed conversion of convertible bonds issued under the financing agreement published February 23, 2018. The number of convertibles converted in December was 12. The number of convertibles remaining during the first tranche for future conversion is 58. Through the conversion, the number of shares and votes increased by 230 769. The terms of the convertibles are published on Episurf Medical AB's website. The total number of shares amounts to 31,631,169, of which 5,221,662 are A shares and 26,409,507 are B shares. The total number of votes after

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During December 2018, 800 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 597,434,903. The total number of registered shares in the company amounts to 419,903,072, of which 19,725,759 are Series A shares, and 400,177,313 are Series B shares.

French private hospital group selects RayStation as sole TPS

Institut de Cancérologie de Bourgogne has chosen RayStation as their sole treatment planning system (TPS). The group consists of three centers, placed in Auxerre, Dijon and Chalon-sur-Saône.The clinics represented by Institut de Cancérologie de Bourgogne are all privately owned, and since 50 percent of the French treatment planning market is privately owned, the order is an important step for RaySearch into this large share of the market in France. RayStation will replace the existing TPS for the group and will function as their sole system. The possibilities to work with adaptive

Attendo's divestment of the healthcare operations in Finland has been completed

Attendo's divestment of the healthcare operations in Finland to the healthcare company Terveystalo has been finalized. The enterprise value of the transaction was EUR 233 million on a cash and debt-free basis. Attendo AB (publ) For further information, please contact: Andreas Koch, Communications and IR Director AttendoPhone: +46 705 09 77 61E-mail: andreas.koch@attendo.com __________________________________________________Attendo - the leading care and healthcare company in the NordicsAttendo is the leading private provider of publicly financed care and healthcare

Terveystalo has completed the acquisition of Finnish healthcare operations of Attendo

Terveystalo Plc Stock exchange release 28 December 2018 at 11:30 a.m. EET Terveystalo has completed the acquisition of Attendo's Finnish Health Services and the combined operations start on 2 January 2019. Attendo's Finnish healthcare operations gain a strong Finnish owner in the transaction. The transaction improves Terveystalo's competitiveness and growth opportunities particularly within services offered to the public sector. Based on the 2017 financials*, Terveystalo and Attendo's Finnish healthcare operations had combined revenue of EUR 924.4 million, adjusted EBITDA of EUR 112.4

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover”) has changed as a result of conversions of in total 1,669,930 class A shares into class B shares carried out in December following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 135,735,195 shares in Medicover, of which 79,204,796 are class A shares, together carrying 79,204,796 votes, 54,130,399 are class B shares, together carrying 5,413,039.90 votes and 2,400,000 are class C shares, together carrying 240,000

Scania delivers 741 gas buses to Bogotá

In November, TransMilenio in Bogotá, selected Scania to deliver 481 Scania Euro 6 gas buses – the cleanest and most silent buses on the market. In the continued renewal of the city’s Bus Rapid Transit system, Scania has now been selected to supply a further 260 gas buses, bringing the total to 741 buses. Scania will hereby supply a majority of buses for the renewal programme.Bogotá is replacing its earlier Euro 2 and Euro 3 buses with the latest in low-emission technology. Scania’s Euro 6 gas buses represent a huge leap in cleaner technology compared with these older-generation buses but

RaySearch receives large RayStation order from major radiotherapy machine manufacturer

RaySearch Laboratories AB (publ) has received a large order for its treatment planning system, RayStation, from a major radiotherapy machine manufacturer. RayStation provides a high-quality user experience and has ground-breaking features like multi-criteria optimization (MCO), ultrafast computation speed, 4D adaptive radiation therapy and machine-learning functionality*.With this order, RayStation will be used with a radiotherapy machine for photon and electron treatments and will support all of the machine’s advanced treatment delivery options. Johan Löf, CEO of RaySearch, says: “We

New shares of Ahlstrom-Munksjö registered with the Finnish Trade Register

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE December 28, 2018 at 10.20 EET  This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore or the United States or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken, in addition to the requirements under Finnish law. For further information, see “Important

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In December 2018, at the request of shareholders, 168 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 158,828,173.7. The total number of registered shares in the company amounts to 576,343,778 shares

Change in number of shares and votes in ÅF AB (publ)

The seventh opportunity to convert debentures into shares under the staff convertible debenture program decided by the Annual General Meeting 2015 occurred in December 2018. Through the conversion the numbers of B-shares and votes have increased by 372. Before the conversion: A-shares: 3 217 752B-shares: 74 148 579Total shares: 77 376 331Votes: 106 336 099 After the conversion: A-shares: 3 217 752B-shares: 74 158 951Total shares: 77 376 703Votes: 106 336 471 Corporate CommunicationÅF AB (publ) The information contained in

Tele2 gives notice to exercise put option in Kazakhstan

Stockholm – Tele2 AB (Tele2) (Nasdaq Stockholm: TEL2 A and TEL2 B) has today given notice to exercise the put option stipulated in the joint venture (the JV) between Tele2 and Kazakhtelecom in Kazakhstan. By serving the put option notice to Kazakhtelecom, Tele2 has initiated the sale process.In March 2016, Tele2 announced the completion of the JV with Kazakhtelecom in Kazakhstan. This became the start of an exceptionally successful cooperation which has created a quickly growing business with strong profitability. The transaction between Kazakhtelecom, Telia Company and Fintur announced

Investment AB Latour announces change of the total number of votes

After conversions of 200 shares from series A to series B in accordance with the company's Articles of Association, Investment AB Latour confirms the following. As per 28 December 2018 the company's share capital amounts unchanged to SEK 133,300,000. The total number of shares of series A amounts to 47,642,248 shares and shares of series B to 592,197,752. The number of votes in the company amounts to 1,068,620,232. Göteborg, December 28, 2018 INVESTMENT AB LATOUR (PUBL)Jan Svensson President and CEO For further information, please contact:Jan Svensson, President and CEO

Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)

Lund, Sweden, 28 December 2018 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announced an increase of the number of shares and votes in NeuroVive of 126,235 as a result of a performed subscription options program (series 2018:1), resolved by the Board of Directors on 15 February 2018.Today, the last trading day of the month, there are in total 91,697,076 shares and votes in NeuroVive Pharmaceutical AB.  This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act (1991:980).

Change in the number of shares and votes in Q-linea AB

Q-linea AB (publ) (”Q-linea” or ”the Company”), today announced that the number of shares and votes in Q-linea has increased during the month of December due to the new share issue carried out in connection with the listing of Q-linea’s shares on Nasdaq Stockholm. A total of 8,088,235 share have been added. At 28 December 2018, which is the last trading day in December, the number of shares and votes amounts to 22,906,915.  For further information, please contact: Anders Lundin, CFO and IR Telephone: +46 706 00 15 20 E-mail: anders.lundin@qlinea.com This information is

Increased number of shares and votes

As previously announced has Vitec Software Group AB (publ), based on the authorization granted by the annual general meeting on 23 April 2018, resolved to carry out a directed new share issue of 2,500,000 class B shares.As of today, the total number of registered and outstanding shares are 32,338,900, divided between 3,350,000 class A shares and 28,988,900 class B shares. The number of votes has increased with 2,500,000 from 59,988,900 to 62,488,900. The share capital has increased with SEK 250,000 from SEK 2,983,890 to SEK 3,233,890 For more information, please contact Patrik

Mycronic secures order for three mask writers

Mycronic has secured an order for three mask writers from an existing customer in Asia. The order consists of one Prexision-8, whose functionality has been limited to the manufacture of photomasks up to generation 6, as well as one FPS8100 and one FPS6100. The order has been booked in the fourth quarter and is valued at between USD 30–35 million. Delivery of the Prexision system is scheduled for the fourth quarter of 2019 and the two FPS systems for the second quarter of 2020. Mycronic’s Business Area Pattern Generators provides mask writers for manufacturing photomasks in several fields

Increased number of shares entered into trade register

Revenio Group Corporation, Stock Exchange Release, December 28, 2018 at 9:00Total of 17,715 new share subscriptions based on the company's 2015A stock options approved by the Board of Directors of Revenio Group Corporation on December 14, 2018, have been entered into the trade register today. The share subscription price under 2015A option rights was 8.23 EUR per share. The subscription period for 2015A options is May 31, 2017-May 31, 2019. After these subscriptions, the number of Revenio Group Corporation's shares and votes will rise to 24,016,476. These increases were recorded in their

Karessa – new research and development area

Karessa Pharma Holding AB (Publ) has received an exclusive license from Uppsalagruppen Medical AB for development of preparations within the benzodiazepine group based on the patented transbuccal drug delivery platform. The objective is with limited contributions develop a prioritized product including preclinical phase, thereafter, finalizing agreements with partners for further development. This means the company will expand to further development area except erectile dysfunction.New area - A wide global market The development will start with midazolam, a pharmaceutical with wide usage

Completed transactions during the fourth quarter 2018

Wallenstam is acquiring more newly issued shares in Convendum, and owns 25 percent of the total number of shares in the company. During the quarter, further transactions were carried out, among other things, shares in Exeger Sweden AB were sold, as well as a property in Härryda and the wind power project Bjälebo.In October, newly issued shares were acquired in Convendum, equivalent to 11.16 percent of the total number of shares, which was communicated in a press release on October 10, 2018. Additional newly issued shares have now been acquired. The transaction means that Wallenstam as of

Conversion of shares

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In December, at the request of shareholders 42 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,278,277,428. The total number of registered shares in the company amounts to 702,342,489 of which 63,992,771 are Class A

Change in number of shares and votes in Sweco AB (publ)

At requests of shareholders, the Swedish Companies Registration Office has registered that 7,963 class A shares have been converted to class B shares during December 2018 with the support of the conversion clause in the Articles of Association. After the registration, as per 28 December 2018, the total number of shares in Sweco amounts to 121,083,819, of which 10,431,991 are of class A, 110,651,828 are of class B representing 21,497,173.8 votes in the company. The share capital amounts to 121,083,819 SEK. On the date and time of publication of this information, Sweco holds 3,982,877

Read original

Financial reporting of Loudspring Oyj in 2019

Loudspring Oyj Company release 28.12.2018, 08:30 (EET) Loudspring Oyj will publish the following financial reports in 2019: ·Financial statement bulletin for the period 1 January - 31 December 2018 on Friday 29 March 2019 ·Q1 summary for the period 1 January – 31 March 2019 on Thursday 25 April 2019 ·Half-year report for the period 1 January - 30 June 2019 on Friday 30 August 2019 ·Q3 summary for the period 1 July – 30 September 2019 on Thursday 31 October 2019. Annual General Meeting is estimated to be held on Friday 26 April 2019. The notice to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top